Some of you may know that there have been trials on the drug, Sirolimus, which is given intravitreally or subconjunctivally (i.e. into the eye).

The idea behind this medication is that it should allow us to decrease our use of steroids which have such horrible side-effects, and it tends not to give so many other side effects, and it is not taken systemically (i.e. into our bodies).

An article has been published that looks at the phase 1 trials which and conclude that it may well help control the uveitis, although it won’t necessarily improve our vision.  The greatest advantage is the ability to come off, or reduce systemic medications.  It is still early days yet, and there are more trials to be undertaken, but it certainly adds another hopeful possibility for the future.

Read the full article at:

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.